CSOL vs CURN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSOL is a Hold and CURN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CSOL’s FA Score shows that 1 FA rating(s) are green whileCURN’s FA Score has 1 green FA rating(s).
- CSOL’s FA Score: 1 green, 4 red.
- CURN’s FA Score: 1 green, 4 red.
Price Growth
CSOL (@Investment Banks/Brokers) experienced а -28.83% price change this week, while CURN (@Investment Banks/Brokers) price change was +0.17% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -1.21%. For the same industry, the average monthly price growth was +1.36%, and the average quarterly price growth was +32.73%.
Reported Earning Dates
CSOL is expected to report earnings on Nov 18, 2024.
CURN is expected to report earnings on Mar 12, 2025.
Industries' Descriptions
@Investment Banks/Brokers (-1.21% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
| CSOL | CURN | CSOL / CURN | |
| Capitalization | 472K | 127M | 0% |
| EBITDA | -490.28K | 19.5M | -3% |
| Gain YTD | 13.223 | -7.317 | -181% |
| P/E Ratio | N/A | 10.38 | - |
| Revenue | 22.8M | 74.6M | 31% |
| Total Cash | 6.45M | 101M | 6% |
| Total Debt | 2.86M | 19.2M | 15% |
CSOL | CURN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 91 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 31 Undervalued | 97 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 77 | |
SMR RATING 1..100 | 91 | 49 | |
PRICE GROWTH RATING 1..100 | 91 | 77 | |
P/E GROWTH RATING 1..100 | 100 | 4 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CSOL's Valuation (31) in the null industry is significantly better than the same rating for CURN (97). This means that CSOL’s stock grew significantly faster than CURN’s over the last 12 months.
CURN's Profit vs Risk Rating (77) in the null industry is in the same range as CSOL (100). This means that CURN’s stock grew similarly to CSOL’s over the last 12 months.
CURN's SMR Rating (49) in the null industry is somewhat better than the same rating for CSOL (91). This means that CURN’s stock grew somewhat faster than CSOL’s over the last 12 months.
CURN's Price Growth Rating (77) in the null industry is in the same range as CSOL (91). This means that CURN’s stock grew similarly to CSOL’s over the last 12 months.
CURN's P/E Growth Rating (4) in the null industry is significantly better than the same rating for CSOL (100). This means that CURN’s stock grew significantly faster than CSOL’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
CSOL and
Correlation & Price change
A.I.dvisor tells us that CSOL and CURN have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSOL and CURN's prices will move in lockstep.
| Ticker / NAME | Correlation To CSOL | 1D Price Change % | ||
|---|---|---|---|---|
| CSOL | 100% | N/A | ||
| CURN - CSOL | 4% Poorly correlated | N/A | ||
| CIIHY - CSOL | 2% Poorly correlated | -0.76% | ||
| DPXCF - CSOL | 2% Poorly correlated | +31.27% | ||
| CMSQF - CSOL | 1% Poorly correlated | N/A | ||
| CLPE - CSOL | -0% Poorly correlated | N/A | ||
More | ||||
CURN and
Correlation & Price change
A.I.dvisor tells us that CURN and SRL have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CURN and SRL's prices will move in lockstep.
| Ticker / NAME | Correlation To CURN | 1D Price Change % | ||
|---|---|---|---|---|
| CURN | 100% | N/A | ||
| SRL - CURN | 20% Poorly correlated | +0.43% | ||
| CIIHF - CURN | 12% Poorly correlated | N/A | ||
| CMSQF - CURN | 11% Poorly correlated | N/A | ||
| DMGGF - CURN | 8% Poorly correlated | -2.84% | ||
| CSOL - CURN | 3% Poorly correlated | N/A | ||
More | ||||